Request Demo
Last update 01 Nov 2025
CAR-NK-CD19 Cells(Beijing Boren Hospital)
Last update 01 Nov 2025
Overview
Basic Info
Drug Type CAR-NK |
Synonyms- |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), Immunologic cytotoxicity |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CAR-NK-CD19 Cells(Beijing Boren Hospital)NCT05410041
Safety and Efficacy of Anti-CD19 CAR-Engineered NK Cells for Relapsed/Refractory B-cell Malignancies: a Multi-center, Open-label, Single-arm Clinical Study
100 Clinical Results associated with CAR-NK-CD19 Cells(Beijing Boren Hospital)
Login to view more data
100 Translational Medicine associated with CAR-NK-CD19 Cells(Beijing Boren Hospital)
Login to view more data
100 Patents (Medical) associated with CAR-NK-CD19 Cells(Beijing Boren Hospital)
Login to view more data
100 Deals associated with CAR-NK-CD19 Cells(Beijing Boren Hospital)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Lymphoma | Phase 1 | China | 25 May 2022 | |
| Chronic Lymphocytic Leukemia | Phase 1 | China | 25 May 2022 | |
| Pre B-cell acute lymphoblastic leukemia | Phase 1 | China | 25 May 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free